Global Folic Acid API Market Research Report 2024

Publication ID:

PB502250611

Publication Date:

February 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Folate, also known as vitamin B9 and folacin, is one of the B vitamins.Manufactured folic acid, which is converted into folate by the body, is used as a dietary supplement and in food fortification as it is more stable during processing and storage. Folate is required for the body to make DNA and RNA and metabolise amino acids necessary for cell division.As humans cannot make folate, it is required in the diet, making it an essential nutrient.It occurs naturally in many foods. The recommended adult daily intake of folate in the U.S. is 400 micrograms from foods or dietary supplements.

Folate in the form of folic acid is used to treat anemia caused by folate deficiency. Folic acid is also used as a supplement by women during pregnancy to reduce the risk of neural tube defects (NTDs) in the baby. Low levels in early pregnancy are believed to be the cause of more than half of babies born with NTDs. More than 80 countries use either mandatory or voluntary fortification of certain foods with folic acid as a measure to decrease the rate of NTDs. Long-term supplementation with relatively large amounts of folic acid is associated with a small reduction in the risk of stroke and an increased risk of prostate cancer.There are concerns that large amounts of supplemental folic acid can hide vitamin B12 deficiency.

The global Folic Acid API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Folic Acid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Folic Acid API.

Report Scope

The Folic Acid API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Folic Acid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Folic Acid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Shengda Biology

XinHeCheng

Zhejiang Medicine

Hebei Jiheng

Manus Aktteva Biopharma LLP

Gnosis SPA

DSM

Jiangxi Tianxin

Changzhou pharmaceutical

Segment by Type

Folic Acid

Compound Folic Acid

Segment by Application

Biochemical Research

Clinical Drugs

Nutritious Food

Consumption by Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Folic Acid API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Folic Acid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Folic Acid API Market Overview

1.1 Product Overview and Scope of Folic Acid API

1.2 Folic Acid API Segment by Type

1.2.1 Global Folic Acid API Market Value Comparison by Type (2024-2030)

1.2.2 Folic Acid

1.2.3 Compound Folic Acid

1.3 Folic Acid API Segment by Application

1.3.1 Global Folic Acid API Market Value by Application: (2024-2030)

1.3.2 Biochemical Research

1.3.3 Clinical Drugs

1.3.4 Nutritious Food

1.4 Global Folic Acid API Market Size Estimates and Forecasts

1.4.1 Global Folic Acid API Revenue 2019-2030

1.4.2 Global Folic Acid API Sales 2019-2030

1.4.3 Global Folic Acid API Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Folic Acid API Market Competition by Manufacturers

2.1 Global Folic Acid API Sales Market Share by Manufacturers (2019-2024)

2.2 Global Folic Acid API Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Folic Acid API Average Price by Manufacturers (2019-2024)

2.4 Global Folic Acid API Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Folic Acid API, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Folic Acid API, Product Type & Application

2.7 Folic Acid API Market Competitive Situation and Trends

2.7.1 Folic Acid API Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Folic Acid API Players Market Share by Revenue

2.7.3 Global Folic Acid API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Folic Acid API Retrospective Market Scenario by Region

3.1 Global Folic Acid API Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Folic Acid API Global Folic Acid API Sales by Region: 2019-2030

3.2.1 Global Folic Acid API Sales by Region: 2019-2024

3.2.2 Global Folic Acid API Sales by Region: 2025-2030

3.3 Global Folic Acid API Global Folic Acid API Revenue by Region: 2019-2030

3.3.1 Global Folic Acid API Revenue by Region: 2019-2024

3.3.2 Global Folic Acid API Revenue by Region: 2025-2030

3.4 North America Folic Acid API Market Facts & Figures by Country

3.4.1 North America Folic Acid API Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Folic Acid API Sales by Country (2019-2030)

3.4.3 North America Folic Acid API Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Folic Acid API Market Facts & Figures by Country

3.5.1 Europe Folic Acid API Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Folic Acid API Sales by Country (2019-2030)

3.5.3 Europe Folic Acid API Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Folic Acid API Market Facts & Figures by Country

3.6.1 Asia Pacific Folic Acid API Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Folic Acid API Sales by Country (2019-2030)

3.6.3 Asia Pacific Folic Acid API Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Folic Acid API Market Facts & Figures by Country

3.7.1 Latin America Folic Acid API Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Folic Acid API Sales by Country (2019-2030)

3.7.3 Latin America Folic Acid API Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Folic Acid API Market Facts & Figures by Country

3.8.1 Middle East and Africa Folic Acid API Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Folic Acid API Sales by Country (2019-2030)

3.8.3 Middle East and Africa Folic Acid API Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Folic Acid API Sales by Type (2019-2030)

4.1.1 Global Folic Acid API Sales by Type (2019-2024)

4.1.2 Global Folic Acid API Sales by Type (2025-2030)

4.1.3 Global Folic Acid API Sales Market Share by Type (2019-2030)

4.2 Global Folic Acid API Revenue by Type (2019-2030)

4.2.1 Global Folic Acid API Revenue by Type (2019-2024)

4.2.2 Global Folic Acid API Revenue by Type (2025-2030)

4.2.3 Global Folic Acid API Revenue Market Share by Type (2019-2030)

4.3 Global Folic Acid API Price by Type (2019-2030)

5 Segment by Application

5.1 Global Folic Acid API Sales by Application (2019-2030)

5.1.1 Global Folic Acid API Sales by Application (2019-2024)

5.1.2 Global Folic Acid API Sales by Application (2025-2030)

5.1.3 Global Folic Acid API Sales Market Share by Application (2019-2030)

5.2 Global Folic Acid API Revenue by Application (2019-2030)

5.2.1 Global Folic Acid API Revenue by Application (2019-2024)

5.2.2 Global Folic Acid API Revenue by Application (2025-2030)

5.2.3 Global Folic Acid API Revenue Market Share by Application (2019-2030)

5.3 Global Folic Acid API Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Shengda Biology

6.1.1 Shengda Biology Corporation Information

6.1.2 Shengda Biology Description and Business Overview

6.1.3 Shengda Biology Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Shengda Biology Folic Acid API Product Portfolio

6.1.5 Shengda Biology Recent Developments/Updates

6.2 XinHeCheng

6.2.1 XinHeCheng Corporation Information

6.2.2 XinHeCheng Description and Business Overview

6.2.3 XinHeCheng Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.2.4 XinHeCheng Folic Acid API Product Portfolio

6.2.5 XinHeCheng Recent Developments/Updates

6.3 Zhejiang Medicine

6.3.1 Zhejiang Medicine Corporation Information

6.3.2 Zhejiang Medicine Description and Business Overview

6.3.3 Zhejiang Medicine Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Zhejiang Medicine Folic Acid API Product Portfolio

6.3.5 Zhejiang Medicine Recent Developments/Updates

6.4 Hebei Jiheng

6.4.1 Hebei Jiheng Corporation Information

6.4.2 Hebei Jiheng Description and Business Overview

6.4.3 Hebei Jiheng Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hebei Jiheng Folic Acid API Product Portfolio

6.4.5 Hebei Jiheng Recent Developments/Updates

6.5 Manus Aktteva Biopharma LLP

6.5.1 Manus Aktteva Biopharma LLP Corporation Information

6.5.2 Manus Aktteva Biopharma LLP Description and Business Overview

6.5.3 Manus Aktteva Biopharma LLP Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Manus Aktteva Biopharma LLP Folic Acid API Product Portfolio

6.5.5 Manus Aktteva Biopharma LLP Recent Developments/Updates

6.6 Gnosis SPA

6.6.1 Gnosis SPA Corporation Information

6.6.2 Gnosis SPA Description and Business Overview

6.6.3 Gnosis SPA Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Gnosis SPA Folic Acid API Product Portfolio

6.6.5 Gnosis SPA Recent Developments/Updates

6.7 DSM

6.6.1 DSM Corporation Information

6.6.2 DSM Description and Business Overview

6.6.3 DSM Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.4.4 DSM Folic Acid API Product Portfolio

6.7.5 DSM Recent Developments/Updates

6.8 Jiangxi Tianxin

6.8.1 Jiangxi Tianxin Corporation Information

6.8.2 Jiangxi Tianxin Description and Business Overview

6.8.3 Jiangxi Tianxin Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Jiangxi Tianxin Folic Acid API Product Portfolio

6.8.5 Jiangxi Tianxin Recent Developments/Updates

6.9 Changzhou pharmaceutical

6.9.1 Changzhou pharmaceutical Corporation Information

6.9.2 Changzhou pharmaceutical Description and Business Overview

6.9.3 Changzhou pharmaceutical Folic Acid API Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Changzhou pharmaceutical Folic Acid API Product Portfolio

6.9.5 Changzhou pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Folic Acid API Industry Chain Analysis

7.2 Folic Acid API Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Folic Acid API Production Mode & Process

7.4 Folic Acid API Sales and Marketing

7.4.1 Folic Acid API Sales Channels

7.4.2 Folic Acid API Distributors

7.5 Folic Acid API Customers

8 Folic Acid API Market Dynamics

8.1 Folic Acid API Industry Trends

8.2 Folic Acid API Market Drivers

8.3 Folic Acid API Market Challenges

8.4 Folic Acid API Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Companies Mentioned:

Shengda Biology

XinHeCheng

Zhejiang Medicine

Hebei Jiheng

Manus Aktteva Biopharma LLP

Gnosis SPA

DSM

Jiangxi Tianxin

Changzhou pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂